Sign in
Taking people in United StatesNo phase

Studies how weight loss changes fat inside muscle in adults with obesity

Tests a 12-week diet for weight loss in adults with obesity and fat within muscle.

Key facts

Who runs it
University of Colorado, Denver
Where
Aurora, United StatesSee the site
Trial code
Registry title
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
Status
Recruiting
People taking part
70 people, planned
Started
31 Jan 2024
Expected to end
1 Sept 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Diet Weight Loss
Record updated
15 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for generally healthy men and women with obesity to study how a 12-week weight-loss diet changes signals from fat tissue inside the thigh muscle.

Age
18 to 70 years
Sex
Men and women
Disease stage
BMI between 30 and 40
Earlier treatment
Less than 1 hour of exercise per week. People taking hormone replacement drugs, blood thinners or thiazoladinediones cannot join.

Main reasons for not taking part

  • Type 1 or Type 2 diabetes
  • Thyroid disease or a history of lung disease
  • Active use of nicotine
  • Severe plasma lipid disorders
  • Women who are pregnant, breastfeeding, going through menopause or peri-menopause, or who have had Polycystic Ovary Syndrome

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Generally healthy men and women aged 18-70
  • BMI between 30-40
  • Less than 1 hour of exercise per week
  • Women:; may be pre or post menopausal

Who cannot take part

  • Taking hormone replacement drugs, blood thinners, or thiazoladinediones
  • Type 1 or Type 2 diabetes
  • Thyroid disease
  • History of lung disease
  • Severe plasma lipid disorders
  • Women:; Currently going through menopause or peri-menopause; Pregnant or breastfeeding; History of Polycystic Ovary Syndrome
  • Active use of nicotine

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • University of Colorado AnschutzAurora, United StatesContact: Bryan Bergman, PhDTaking people

About the trial

What the trial wants to find out

The goal of this intervention study is to learn about how weight loss impacts molecular signaling of intermuscular adipose tissue (IMAT) in individuals with obesity. The main question it aims to answer is how inflammatory molecules secreted by IMAT promote muscle insulin resistance and inflammation, and how these same molecules are diminished after weight loss. Following screening visits involving body composition measures, blood testing, strength testing, and a thigh muscle biopsy, participants will go through a 12-week dietary intervention for weight loss. After 12 weeks, this will be followed by the same testing and biopsies that were completed before the intervention. Researchers will then compare outcomes of individuals who lost weight to individuals who did not lose weight.

The 2 groups in the trial

  • Diet Weight LossTreatment being tested

    Low calorie meal replacement shakes

  • Delayed InterventionNo study treatment, for comparison

    Normal feeding

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
Plain-language title
Studies how weight loss changes fat inside muscle in adults with obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06129110, who can take part
Record updated
15 May 2026